FDA Import Refusal 1FX-2681698-4/10002/6 — CARE FORMULATION LABS PRIVATE LI

CARE FORMULATION LABS PRIVATE LI — FEI 3016981229

The FDA refused shipment 1FX-2681698-4/10002/6 from CARE FORMULATION LABS PRIVATE LI (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 1 other import refusal on record.

Refusal Details

Date
Oct 8, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
62GDA99 ANTI-INFLAMMATORY N.E.C.
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.